Cargando…
Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1
Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy in adults for which there is currently no treatment. The pathogenesis of this autosomal dominant disorder is associated with the expansion of CTG repeats in the 3′-UTR of the DMPK gene. DMPK transcripts with expanded CUG repeats (...
Autores principales: | López-Morató, Marta, Brook, John David, Wojciechowska, Marzena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968088/ https://www.ncbi.nlm.nih.gov/pubmed/29867749 http://dx.doi.org/10.3389/fneur.2018.00349 |
Ejemplares similares
-
Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1
por: Wojciechowska, Marzena, et al.
Publicado: (2014) -
Global Increase in Circular RNA Levels in Myotonic Dystrophy
por: Czubak, Karol, et al.
Publicado: (2019) -
An Overview of Circular RNAs and Their Implications in Myotonic Dystrophy
por: Czubak, Karol, et al.
Publicado: (2019) -
Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy
por: Wojciechowska, Marzena, et al.
Publicado: (2018) -
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1
por: Liu, Jie, et al.
Publicado: (2021)